Proteomic analysis reveals innate immune activity in intestinal transplant dysfunction

Transplantation

Volumn 92, Issue 1, 2011, Pages 112-119

  Kumar, Anjuli R ^a   Li, Xiaoxiao ^a   Leblanc, James F ^a   Farmer, Douglas G ^a   Elashoff, David ^a   Braun, Jonathan ^a   Ziring, David ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

Innate immunity; Intestinal transplantation; Proteomics; Rejection

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 8; NEUTROPHIL PEPTIDE; PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; INNATE IMMUNITY; INTESTINE BIOPSY; INTESTINE TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; STOMA;

ADULT; ALPHA-DEFENSINS; CHILD; CYTOKINES; ENTEROSTOMY; GRAFT REJECTION; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTERLEUKIN-8; INTESTINES; PROTEOMICS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959641848     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31821d262b     Document Type: Article

References (38)

1. Kaufman SS, Atkinson JB, Bianchi A, et al. Indications for pediatric intestinal transplantation: A position paper of the American Society of Transplantation. Pediatr Transplant 2001; 5: 80.
2. Hanto DW, Fishbein TM, Pinson CW, et al. Liver and intestine transplantation: Summary analysis, 1994-2003. Am J Transplant 2005; 5: 916.
3. Fishbein TM. Intestinal transplantation. N Engl J Med 2009; 361: 998.
4. Ruiz P, Bagni A, Brown R, et al. Histological criteria for the identification of acute cellular rejection in human small bowel allografts: Results of the pathology workshop at the VIII International Small Bowel Transplant Symposium. Transplant Proc 2004; 36: 335.
5. WuT, Abu-Elmagd K, Bond G, et al. A schema for histologic grading of small intestine allograft acute rejection. Transplantation 2003; 75: 1241.
6. Sudan D, Vargas L, Sun Y, et al. Calprotectin: A novel noninvasive marker for intestinal allograft monitoring. Ann Surg 2007; 246: 311.
7. Mayer L. Mucosal immunity and gastrointestinal antigen processing. J Pediatr Gastroenterol Nutr 2000; 30(suppl): S4.
8. Iwaki Y, Starzl TE, Yagihashi A, et al. Replacement of donor lymphoid tissue in small-bowel transplants. Lancet 1991; 337: 818.
9. Newell KA. Transplantation of the intestine: Is it truly different? Am J Transplant 2003; 3: 1.
10. LaRosa DF, Rahman AH, et al. The innate immune system in allograft rejection and tolerance. J Immunol 2007; 178: 7503.
11. Farmer DG, McDiarmid SV, Kuniyoshi J, et al. Intragraft expression of messenger RNA for interleukin-6 and tumor necrosis factor-alpha is a predictor of rat small intestine transplant rejection. J Surg Res 1994; 57: 138.
12. Christopher K, Mueller TF, Ma C, et al. Analysis of the innate and adaptive phases of allograft rejection by cluster analysis of transcriptional profiles. J Immunol 2002; 169: 522.
13. He H, Stone JR, Perkins DL. Analysis of robust innate immune response after transplantation in the absence of adaptive immunity1. Transplantation 2002; 73: 853.
14. Farmer DG, Shen X-D, Amersi F, et al. CD62 blockade with P-selectin glycoprotein ligand-immunoglobulin fusion protein reduces ischemiareperfusion injury after rat intestinal transplantation. Transplantation 2005; 79: 44.
15. Kaser A, Blumberg RS. Endoplasmic reticulum stress and intestinal inflammation. Mucosal Immunol 2010; 3: 11.
16. Nilsson T, Mann M, Aebersold R, et al. Mass spectrometry in highthroughput proteomics: Ready for the big time. Nat Meth 2010; 7: 681.
17. Li Q, Zhang Q, Xu G, et al. Metabonomics study of intestinal transplantation using ultrahigh-performance liquid chromatography time-offlight mass spectrometry. Digestion 2008; 77: 122.
18. McDiarmid SV, Farmer DG, Kuniyoshi JS, et al. Perforin and granzyme B. Cytolytic proteins up-regulated during rejection of rat small intestine allografts. Transplantation 1995; 59: 762.
19. SarwalMM.Deconvoluting the 'omics' for organ transplantation. Curr Opin Organ Transplant 2009; 14: 544.
20. Hedges SR, Agace WW, Svanborg C. Epithelial cytokine responses and mucosal cytokine networks. Trends Microbiol 1995; 3: 266.
21. Obara H, Nagasaki K, Hsieh CL, et al. IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses. Am J Transplant 2005; 5: 2094.
22. Yadavalli GK, Auletta JJ, Gould MP, et al. Deactivation of the innate cellular immune response following endotoxic and surgical injury. Exp Mol Pathol 2001; 71: 209.
23. Shi J. Defensins and Paneth cells in inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 1284.
24. Wehkamp J, Schwind B, Herrlinger KR, et al. Innate immunity and colonic inflammation: Enhanced expression of epithelial alpha-defensins. Dig Dis Sci 2002; 47: 1349.
25. Wehkamp J, Wang G, Kubler I, et al. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol 2007; 179: 3109.
26. Fishbein T, Novitskiy G, Mishra L, et al. NOD2-expressing bone marrow- derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut 2008; 57: 323.
27. Nanthakumar NN, Young C, Ko JS, et al. Glucocorticoid responsiveness in developing human intestine: Possible role in prevention of necrotizing enterocolitis.AmJ Physiol Gastrointest Liver Physiol 2005; 288: G85.
28. Salzman NH, Underwood MA, Bevins CL. Paneth cells, defensins, and the commensal microbiota: A hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol 2007; 19: 70.
29. Salzman NH, Hung K, Haribhai D, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010; 11: 76.
30. Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci USA 2008; 105: 20858.
31. Kitchens WH, Uehara S, Chase CM, et al. The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 2006; 81: 811.
32. Pêche H, Trinité B, Martinet B, et al. Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors. Am J Transplant 2005; 5: 255.
33. Fu F, Li Y, Qian S, et al. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II, CD80dim, CD86) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996; 62: 659.
34. Jaeschke H, Farhood A, Smith C. Neutrophils contribute to ischemia/ reperfusion injury in rat liver in vivo. FASEB J 1990; 4: 3355.
35. Morita K, Miura M, Paolone DR, et al. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. J Immunol 2001; 167: 2979.
36. Farmer DG, Anselmo D, Shen XD, et al. Disruption of P-selectin signaling modulates cell trafficking and results in improved outcomes after mouse warm intestinal ischemia and reperfusion injury. Transplantation 2005; 80: 828.
37. Yang D, Chen Q, Chertov O, et al. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol 2000; 68: 9.
38. Grigat J, Soruri A, Forssmann U, et al. Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. J Immunol 2007; 179: 3958.